CJC-1295 and Ipamorelin: two routes into growth-axis research

CJC-1295 belongs to the family of synthetic growth-hormone-releasing-hormone analogues. Ipamorelin was characterised as a selective growth-hormone secretagogue in experimental systems. They engage the growth axis through different receptor mechanisms.

The distinction matters when interpreting a protocol: analogue structure, duration of observation and assay context can change the question being tested. A product label is not a substitute for the methods section of a cited study.

Apex catalogue records distinguish CJC-1295 No DAC products from other identities and list presentation and dosage separately. No listing implies an approved clinical use.